Bristol-Myers Squibb
BMY
BMY
2,456 hedge funds and large institutions have $116B invested in Bristol-Myers Squibb in 2022 Q3 according to their latest regulatory filings, with 98 funds opening new positions, 986 increasing their positions, 1,014 reducing their positions, and 133 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,456
Holders Change
-67
Holders Change %
-2.66%
% of All Funds
42.47%
Holding in Top 10
113
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-14.39%
% of All Funds
1.95%
New
98
Increased
986
Reduced
1,014
Closed
133
Calls
$1.98B
Puts
$1.57B
Net Calls
+$411M
Net Calls Change
-$186M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$1.02B |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$572M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$368M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$259M |
| 5 |
BlackRock
New York
|
+$239M |
